Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Maze Therapeutics, Inc. (MAZE) Investor Outlook: Strong Buy Ratings and Potential 32.98% Upside 17 October 2025
Claritev Corporation (CTEV) Stock Analysis: Healthcare Data Leader with 24.71% Upside Potential 17 October 2025
Upstream Bio, Inc. (UPB) Investor Outlook: Unpacking the 123% Potential Upside in Biotech 17 October 2025
Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 15.8% Upside Potential in the Cannabis Sector 17 October 2025
Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Landscape with a 44.82% Upside Potential 17 October 2025
Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A 200% Upside Potential in the Biotech Space 17 October 2025
Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 72% Potential Upside Beckons Amid Biotech Innovation 17 October 2025
Talkspace, Inc. (TALK) Stock Analysis: A 64.95% Upside Potential Amidst Growing Healthcare Demand 17 October 2025
Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech Player with Remarkable Revenue Growth and Promising Drug Pipeline 17 October 2025
Anavex Life Sciences Corp. (AVXL) Stock Analysis: A 281% Potential Upside on the Horizon 17 October 2025
Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A 38.76% Potential Upside in Cutting-Edge Gene Editing 17 October 2025
RxSight, Inc. (RXST) Stock Analysis: Evaluating Growth Potential Amidst Market Challenges 17 October 2025
Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 58% Potential Upside with Strong Buy Ratings 17 October 2025
Fortrea Holdings Inc. (FTRE) Stock Analysis: Can This Biotech Innovator Turn Challenges into Opportunities? 17 October 2025
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Promising 105.95% Upside Potential 17 October 2025
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech Gem with a 351.84% Potential Upside 17 October 2025
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth in Healthcare Diagnostics with a Potential 11% Upside 17 October 2025
Cogent Biosciences, Inc. (COGT) Stock Analysis: Eyeing a 26% Upside with Precision Therapies in Focus 17 October 2025
Hercules Plc Training 2,000 Workers to Help Solve the UK Infrastructure Skills Crisis (Video) 17 November 2025
Firering Strategic Minerals $1M Ricca Settlement Injects Momentum into Lithium Strategy (Video) 14 November 2025
ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video) 11 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
